UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:	November 27, 2023 4:00 P.M.

Form:	S-3
CIK: 0001799448 Company Name: Aligos Therapeutics, Inc. File Number: 333-275636